KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universal Health Services (UHS) Gains from Sales and Divestitures (2016 - 2025)

Universal Health Services (UHS) has disclosed Gains from Sales and Divestitures for 17 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gains from Sales and Divestitures fell 34.67% year-over-year to $1.2 million, compared with a TTM value of $1.2 million through Dec 2025, down 34.67%, and an annual FY2025 reading of $1.2 million, down 34.67% over the prior year.
  • Gains from Sales and Divestitures was $1.2 million for Q4 2025 at Universal Health Services, down from $1.8 million in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $2.2 million in Q4 2021 and bottomed at $1.2 million in Q4 2025.
  • Average Gains from Sales and Divestitures over 5 years is $1.9 million, with a median of $2.0 million recorded in 2023.
  • The sharpest move saw Gains from Sales and Divestitures increased 1.54% in 2021, then crashed 34.67% in 2025.
  • Year by year, Gains from Sales and Divestitures stood at $2.2 million in 2021, then decreased by 3.48% to $2.1 million in 2022, then decreased by 7.11% to $2.0 million in 2023, then fell by 10.33% to $1.8 million in 2024, then plummeted by 34.67% to $1.2 million in 2025.
  • Business Quant data shows Gains from Sales and Divestitures for UHS at $1.2 million in Q4 2025, $1.8 million in Q4 2024, and $2.0 million in Q4 2023.